Medicines and Healthcare products Regulatory Agency
Featured
Press release
Vimseltinib (romvimza) approved for use in adults to treat tenosynovial giant cell tumours
As with any medicine, the MHRA will keep the safety and effectiveness of vimseltinib (romvizma) under close review.
Press release
You've got the grades, but don't pass on your health
Medicines and medical devices regulator issues health advice for teens off to university.
News story
MHRA reaffirms the safety of childhood vaccination
Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases
Press release
MHRA advises quarantine of medical devices supplied without appropriate conformity markings
The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations or with the EU Medical Devices Regulation.
Press release
UK first in Europe to authorise orforglipron for weight management and type 2 diabetes
As with all GLP-1 receptor agonists, the MHRA will keep the safety and effectiveness of orforglipron under close review.
Press release
Taking medication this summer? What you need to know about sun and heat exposure
Some medicines can make you more sensitive to the sun or increase the risk of dehydration without you realising it. The MHRA is encouraging people to know the risks and stay protected this summer.
Our management
